These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


254 related items for PubMed ID: 23693156

  • 1. [The role of immunosuppressive agents in Kawasaki disease: a discussion of two cases].
    Peyre M, Laroche C, Etchecopar C, Brosset P.
    Arch Pediatr; 2013 Jul; 20(7):748-53. PubMed ID: 23693156
    [Abstract] [Full Text] [Related]

  • 2. A girl with extremely refractory Kawasaki disease: an instructive case with unusual course and outcome.
    Kossiva L, Karanassios E, Papadopoulos G, Karavanaki K.
    Cardiol Young; 2012 Aug; 22(4):461-5. PubMed ID: 21933460
    [Abstract] [Full Text] [Related]

  • 3. Kawasaki disease: a comprehensive review of treatment options.
    Patel RM, Shulman ST.
    J Clin Pharm Ther; 2015 Dec; 40(6):620-5. PubMed ID: 26547265
    [Abstract] [Full Text] [Related]

  • 4. Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.
    Tremoulet AH, Jain S, Jaggi P, Jimenez-Fernandez S, Pancheri JM, Sun X, Kanegaye JT, Kovalchin JP, Printz BF, Ramilo O, Burns JC.
    Lancet; 2014 May 17; 383(9930):1731-8. PubMed ID: 24572997
    [Abstract] [Full Text] [Related]

  • 5. Management of acute and refractory Kawasaki disease.
    Tacke CE, Burgner D, Kuipers IM, Kuijpers TW.
    Expert Rev Anti Infect Ther; 2012 Oct 17; 10(10):1203-15. PubMed ID: 23199405
    [Abstract] [Full Text] [Related]

  • 6. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
    Hsieh KS, Weng KP, Lin CC, Huang TC, Lee CL, Huang SM.
    Pediatrics; 2004 Dec 17; 114(6):e689-93. PubMed ID: 15545617
    [Abstract] [Full Text] [Related]

  • 7. [Kawasaki disease: what you need to know].
    Bajolle F, Laux D.
    Arch Pediatr; 2012 Nov 17; 19(11):1264-8. PubMed ID: 22921712
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and limitation of infliximab treatment for children with Kawasaki disease intractable to intravenous immunoglobulin therapy: report of an open-label case series.
    Mori M, Imagawa T, Hara R, Kikuchi M, Hara T, Nozawa T, Miyamae T, Yokota S.
    J Rheumatol; 2012 Apr 17; 39(4):864-7. PubMed ID: 22337241
    [Abstract] [Full Text] [Related]

  • 9. Epidemiologic study of Kawasaki disease and cases resistant to IVIG therapy in Thailand.
    Durongpisitkul K, Sangtawesin C, Khongphatthanayopthin A, Panamonta M, Sopontammarak S, Sittiwangkul R, Pongpanich B.
    Asian Pac J Allergy Immunol; 2006 Mar 17; 24(1):27-32. PubMed ID: 16913186
    [Abstract] [Full Text] [Related]

  • 10. Corticosteroid treatment of refractory Kawasaki disease.
    Lang BA, Yeung RS, Oen KG, Malleson PN, Huber AM, Riley M, Ebbeson R, Ramsey SE, Laxer RM, Silverman ED, McCrindle BW, Ratnapalan S, Feldman BM.
    J Rheumatol; 2006 Apr 17; 33(4):803-9. PubMed ID: 16583481
    [Abstract] [Full Text] [Related]

  • 11. Guideline-Concordant Treatment of Kawasaki Disease With Immunoglobulin and Aspirin and the Incidence of Coronary Artery Aneurysm.
    Michihata N, Matsui H, Fushimi K, Yasunaga H.
    Clin Pediatr (Phila); 2015 Oct 17; 54(11):1076-80. PubMed ID: 25573948
    [Abstract] [Full Text] [Related]

  • 12. [Kawasaki disease in children--9 years experience].
    Kowalczyk M, Kawalec W, Daszkowska-York J, Turska-Kmieć A, Brzezińska-Rajszys G, Sobielarska D, Ziółkowska L, Kościesza A, Jagiełłowicz D, Mirecka-Rola A.
    Med Wieku Rozwoj; 2005 Oct 17; 9(2):179-93. PubMed ID: 16085959
    [Abstract] [Full Text] [Related]

  • 13. Simultaneous development of Kawasaki disease following acute human adenovirus infection in monozygotic twins: A case report.
    Fukuda S, Ito S, Fujiwara M, Abe J, Hanaoka N, Fujimoto T, Katsumori H.
    Pediatr Rheumatol Online J; 2017 May 16; 15(1):39. PubMed ID: 28511718
    [Abstract] [Full Text] [Related]

  • 14. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
    Furukawa T, Kishiro M, Akimoto K, Nagata S, Shimizu T, Yamashiro Y.
    Arch Dis Child; 2008 Feb 16; 93(2):142-6. PubMed ID: 17962370
    [Abstract] [Full Text] [Related]

  • 15. Infections and Kawasaki disease: implications for coronary artery outcome.
    Benseler SM, McCrindle BW, Silverman ED, Tyrrell PN, Wong J, Yeung RS.
    Pediatrics; 2005 Dec 16; 116(6):e760-6. PubMed ID: 16322132
    [Abstract] [Full Text] [Related]

  • 16. Infliximab as a novel therapy for refractory Kawasaki disease.
    Weiss JE, Eberhard BA, Chowdhury D, Gottlieb BS.
    J Rheumatol; 2004 Apr 16; 31(4):808-10. PubMed ID: 15088313
    [Abstract] [Full Text] [Related]

  • 17. Advances in the treatment of Kawasaki disease.
    Dominguez SR, Anderson MS.
    Curr Opin Pediatr; 2013 Feb 16; 25(1):103-9. PubMed ID: 23283289
    [Abstract] [Full Text] [Related]

  • 18. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.
    Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA, Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.
    Pediatrics; 2004 Dec 16; 114(6):1708-33. PubMed ID: 15574639
    [Abstract] [Full Text] [Related]

  • 19. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.
    Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA, Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association, American Academy of Pediatrics.
    Circulation; 2004 Oct 26; 110(17):2747-71. PubMed ID: 15505111
    [Abstract] [Full Text] [Related]

  • 20. A 12-week-old male with a 10-day history of fever.
    Bhatt ST, Hageman JR, Bartlett A, Trivedi K.
    Pediatr Ann; 2014 May 26; 43(5):e111-5. PubMed ID: 24877492
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.